Assessing the impact of a combination of sofosbuvir and daclatasvir treatment for hepatitis C virus infection on heart rate, rhythm and heart rate variability using 24-hour ECG monitoring

Assessing the impact of a combination of sofosbuvir and daclatasvir treatment for hepatitis C virus infection on heart rate, rhythm and heart rate variability using 24-hour ECG monitoring

Abstract Background Direct-acting antiviral agents (DAAs) cure patients with hepatitis C virus (HCV) infection. Concerns have arisen the occurrence of significant bradyarrhythmias during treatment with DAAs. The aim of this study was to assess the impact of a DAA combination for the treatment of HCV...

Full description

Bibliographic Details
Main Authors: Ahmed Mohamed El Missiri, Mona Mostafa Rayan, Mohamed Medhat Awad, Ahmed Ibrahim El Desoky
Format: Article
Language:English
Published: SpringerOpen 2020-07-01
Series:The Egyptian Heart Journal
Subjects:
Sofosbuvir
Daclatasvir
Bradycardia
Holter
ECG monitoring
Online Access:http://link.springer.com/article/10.1186/s43044-020-00070-4

Internet

http://link.springer.com/article/10.1186/s43044-020-00070-4

Similar Items